Natixis’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $864 | Buy |
+20
| New | +$864 | ﹤0.01% | 972 |
|
|
2025
Q1 | – | Sell |
-18,500
| Closed | -$508K | – | 961 |
|
|
2024
Q4 | $508K | Hold |
18,500
| – | – | ﹤0.01% | 692 |
|
|
2024
Q3 | $471K | Buy |
+18,500
| New | +$471K | ﹤0.01% | 637 |
|
|
2023
Q4 | – | Sell |
-31,800
| Closed | -$839K | – | 1024 |
|
|
2023
Q3 | $839K | Buy |
31,800
+25,800
| +430% | +$680K | 0.01% | 516 |
|
|
2023
Q2 | $103K | Sell |
6,000
-9,000
| -60% | -$155K | ﹤0.01% | 783 |
|
|
2023
Q1 | $249K | Buy |
+15,000
| New | +$249K | ﹤0.01% | 713 |
|
|
2021
Q4 | – | Sell |
-29,375
| Closed | -$1.38M | – | 1231 |
|
|
2021
Q3 | $1.38M | Buy |
29,375
+23,725
| +420% | +$1.11M | ﹤0.01% | 806 |
|
|
2021
Q2 | $344K | Buy |
5,650
+1,250
| +28% | +$76.1K | ﹤0.01% | 771 |
|
|
2021
Q1 | $271K | Buy |
+4,400
| New | +$271K | ﹤0.01% | 1006 |
|